JSA
Rohitashwa Prasad, Partner, JSA outlines the business strategies that pharma companies need to adopt for risk mitigation to deal with the impact of COVID – 19
The healthcare industry is a silver lining in the dark clouds looming over the Indian economy since the outbreak of the COVID-19 pandemic. Demand for certain kinds of drugs, devices and healthcare facilities is expected to grow significantly in the near future.
Please click here to read the full article.
As per the rules of the Bar Council of India, we are not permitted to solicit work and advertise. By clicking on the “I AGREE” button below, you acknowledge the following:
If you have any legal issues, you, in all cases, must seek independent legal advice.
We use cookies to enhance your experience. By continuing to visit this website you agree to our use of cookies.
